RoferonA is a pharmaceutical drug that is classified as an immunomodulator and anti-viral agent. It is a form of alpha-interferon, which is a naturally occurring protein produced by the human immune system. RoferonA is derived from human leukocytes, or white blood cells, and is administered through injection.
RoferonA is primarily used for the treatment of chronic viral infections, including hepatitis B and C, and certain types of cancers such as hairy cell leukemia, malignant melanoma, and chronic myelogenous leukemia. It works by stimulating the body's immune response to target and destroy abnormal cells or viruses.
The drug is generally prescribed by healthcare professionals and is only available through a prescription. RoferonA is available in different strengths and dosages, depending on the specific condition being treated. The dosage and administration of RoferonA may vary based on individual patient characteristics, including body weight, overall health, and the severity of the condition.
As with any medication, RoferonA may have certain side effects, which can include flu-like symptoms such as fever, chills, fatigue, muscle aches, and nausea. Some individuals may also experience depression or changes in mood. It is essential to consult with a healthcare provider before starting RoferonA to discuss potential benefits and risks. Prompt reporting of any adverse reactions is crucial to facilitate appropriate medical intervention.
